Bausch Health Cos Inc (BHC) 13F Ownership Report (Q2 2026)

BHC ranks #2655 out of 37501 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

BHC is a top-conviction position for Paulson & Co. Inc. — at 14.0% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

Geode Capital Management, LLC has added to its BHC position for two straight quarters, increasing it by $17.2M to reach $33.2M today.

Paulson & Co. Inc. has trimmed its BHC position for two straight quarters, cutting it by $148.0M while still holding $361.2M.

BHC is up 5.6% today, and institutions have been net buyers of $77.6M this quarter — today's price move and the underlying institutional flow are pointing the same direction.

BHC reported a net loss of $1.1B over the trailing twelve months.

• Not yet profitable — net loss of $1.1B over the trailing twelve months
• Revenue grew 10.1% year over year
• Net income declined year over year, from $98.0M to -$1.1B
• Generated $1.4B in positive operating cash flow
• Current ratio of 1.47x — below the conventional 1.5x liquidity buffer